GRIFOLS reported €330.18M in EBITDA for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebitda Change
Alcon AG ALC:SW 484M 16M
Amadeus IT AMS:SM € 206.6M 61.3M
Amarin AMRN:US $ 1.82M 7.74M
AstraZeneca AZN:LN 2784M 588M
Bayer BAYN:GR € 2089M 946M
Ferrovial FER:SM € 188M 56M
Fresenius FRE:GR € 1711M 31M
Fresenius Medical Care FME:GR € 886M 14.67M
Galapagos GLPG:NA € -70.14M 39.37M
GlaxoSmithKline GSK:LN 3660M 1034M
GRIFOLS GRF:SM € 330.18M 44.07M
H. Lundbeck A/S LUN:DC 933M 62M
Hikma Pharmaceutical HIK:LN 358M 9M
Inditex ITX:SM € 1866M 631M
Merck MRK:GR € 1551M 25M
Novartis NOVN:VX SF 4837M 65M
Philips PHIA:NA € 754M 29M